New treatment strategies for COPD: Pairing the new with the tried and true

Postgraduate Medicine

Volumn 117, Issue 3, 2005, Pages 27-34

  Cote, Claudia G ^a,b   Celli, Bartolome R ^c,d  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b Bay Pines VA Medical Center   (United States)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d ST ELIZABETH'S MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

A METHAPRED; ACETYLCYSTEINE; ANTIBIOTIC AGENT; ANTIOXIDANT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; CROMOGLYCATE DISODIUM; FLUTICASONE PROPIONATE; FORMOTEROL FUMARATE; IPRATROPIUM BROMIDE; IPRATROPIUM BROMIDE PLUS SALBUTAMOL SULFATE; LONG ACTING DRUG; METHYLPREDNISOLONE SODIUM SUCCINATE; MUCOLYTIC AGENT; NEDOCROMIL; NEDOCROMIL SODIUM; OSELTAMIVIR; PHOSPHODIESTERASE INHIBITOR; PNEUMOCOCCUS VACCINE; RELENTA; SALBUTAMOL; SALMETEROL; SALMETEROL XINAFOATE; THEOPHYLLINE; TIOTROPIUM BROMIDE; UNCLASSIFIED DRUG; ZANAMIVIR; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; ANTIVIRUS AGENT; EXPECTORANT AGENT;

ARTIFICIAL VENTILATION; CATARACT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONFERENCE PAPER; DIABETES MELLITUS; DISEASE SEVERITY; FORCED EXPIRATORY VOLUME; HUMAN; LUNG RESECTION; LUNG TRANSPLANTATION; METERED DOSE INHALER; NAUSEA; OSTEOPOROSIS; OXYGEN THERAPY; QUALITY OF LIFE; SEIZURE; SKIN DEFECT; SMOKING CESSATION; SPIROMETRY; SURVIVAL TIME; TACHYCARDIA; VOMITING; REVIEW;

ADRENAL CORTEX HORMONES; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; ANTIVIRAL AGENTS; BRONCHODILATOR AGENTS; CHOLINERGIC ANTAGONISTS; EXPECTORANTS; HUMANS; OXYGEN INHALATION THERAPY; PHOSPHODIESTERASE INHIBITORS; PNEUMOCOCCAL VACCINES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING CESSATION;

EID: 15744398424     PISSN: 00325481     EISSN: None     Source Type: Journal    
DOI: 10.3810/pgm.2005.03.1594     Document Type: Conference Paper

References (30)

1. Celli BR, MacNee W; ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004;23(6):932-46
2. Pauwels RA, Buist AS, Calverley PM, et al; GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001;163(5):1256-76
3. 1. The Lung Health Study. JAMA 1994;272(19):1497-505
4. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Nocturnal Oxygen Therapy Trial Group. Ann Intern Med 1980;93(3):391-8
5. Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Report of the Medical Research Council Working Party. Lancet 1981;1(8222):681-6
6. Brochard L, Mancebo J, Wysocki M, et al. Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease. N Engl J Med 1995;333(13):817-22
7. Fiore MC, Bailey WC, Cohen SJ, et al. Treating tobacco use and dependence. Rockville, Md: US Dept Of Health and Human Services, Public Health Service, 2000
8. Belman MJ, Botnick WC, Shin JW. Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996;153(3):967-75
9. O'Donnell DE, Lam M, Webb KA. Measurement of symptoms, lung hyperinflation, and endurance during exercise in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;158(5 Pt 1):1557-65
10. Rennard SI, Anderson W, ZuWallack R, et al. Use of a long-acting inhaled beta2-adrenergic agonist, salmeterol xinafoate, in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;163(5):1087-92
11. Jones PW, Bosh TK. Quality of life changes in COPD patients treated with salmeterol. Am J Respir Crit Care Med 1997;155(4):1283-9
12. Casaburi R, Mahler DA, Jones PW, et al. A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease. Eur Respir J 2002;19(2):217-24
13. ZuWallack RL, Mahler DA, Reilly D, et al. Salmeterol plus theophylline combination therapy in the treatment of COPD. Chest 2001;119(6):1661-70
14. Pauwels RA, Lofdahl CG, Laitinen LA, et al. Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease. N Engl J Med 1999;340(25):1948-53
15. Burge PS, Calverley PM, Jones PW, et al. Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial. BMJ 2000;320(7245):1297-303
16. Lung Health Study Research Group. Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease. N Engl J Med 2000;343(26):1902-9
17. Sin DD, Tu JV. Inhaled corticosteroids and the risk of mortality and readmission in elderly patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;164(4):580-4
18. Soriano JB, Vestbo J, Pride NB, et al. Survival in COPD patients after regular use of fluticasone propionate and salmeterol in general practice. Eur Respir J 2002;20(4):819-25
19. Anthonisen NR, Manfreda J, Warren CP, et al. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 1987;106(2):196-204
20. Pulmonary rehabilitation-1999. American Thoracic Society. Am J Respir Crit Care Med 1999;159(5 Pt 1):1666-82
21. Cooper JD, Trulock EP, Triantafillou AN, et al. Bilateral pneumectomy (volume reduction) for chronic obstructive pulmonary disease. J Thorac Cardiovasc Surg 1995;109(1):106-16; discussion 116-9
22. Casaburi R, Porszasz J, Burns MR, et al. Physiologic benefits of exercise training in rehabilitation of patients with severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1997;155(5):1541-51
23. Maltais F, LeBlanc P, Simard C, et al. Skeletal muscle adaptation to endurance training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996;154(2 Pt 1):442-7
24. Celli BR. The clinical use of upper extremity exercise. Clin Chest Med 1994;15(2):339-49
25. Fishman A, Martinez F, Naunheim K, et al; National Emphysema Treatment Trial Research Group. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med 2003;348(21):2059-73
26. International guidelines for the selection of lung transplant candidates. The American Society for Transplant Physicians (ASTP)/American Thoracic Society (ATS)/European Respiratory Society (ERS)/International Society for Heart and Lung Transplantation (ISHLT). Am J Respir Crit Care Med 1998;158(1):335-9
27. Niewoehner DE, Erbland ML, Deupree RH, et al. Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group. N Engl J Med 1999;340(25):1941-7
28. Bott J, Carroll MP, Conway JH, et al. Randomised controlled trial of nasal ventilation in acute ventilatory failure due to chronic obstructive airways disease. Lancet 1993;341(8860):1555-7
29. Meecham Jones DJ, Paul EA, Jones PW, et al. Nasal pressure support ventilation plus oxygen compared with oxygen therapy alone in hypercapnic COPD. Am J Respir Crit Care Med 1995;152(2):538-44
30. Casanova C, Celli BR, Tost L, et al. Long-term controlled trial of nocturnal nasal positive pressure ventilation in patients with severe COPD. Chest 2000;118(6):1582-90